Delivery Order SPE2DB22D1103-SPE2DB25FTAV4
Award Date
10/23/24
Potential Completion Date
10/24/24
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $47,337.10 with a firm fixed price, and the ultimate completion date is April 27, 2023. The contract is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,903.12 with a firm fixed price. The contract covers the supply of "MENQUADFI VIAL 0.5ML" medical products to support military healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,566.12 firm fixed-price delivery order is for the supply of MENQUADFI VIAL 0.5ML medical products. The contract has an ultimate completion date of August 30, 2024 and was awarded on August 29, 2024. Amerisourcebergen is a for-profit organization that specializes in distributing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,504.72 firm fixed-price delivery order is for the procurement of MENQUADFI VIAL 0.5ML, a medical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,281.73 firm fixed-price delivery order contract is for the supply of MENQUADFI VIAL 0.5ML medical products, with a completion date of July 15, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,911.68 firm fixed-price delivery order covers the supply of 4567773275 MENQUADFI VIAL 0.5ML, a medical product, with a period of performance through April 3, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,756.20 firm fixed-price delivery order covers the supply of MENQUADFI VIAL 0.5ML, a medical product, with a period of performance through March 8, 2024. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,080.39 firm fixed-price delivery order contract is for the procurement of MENQUADFI VIAL 0.5ML medical supplies, with a completion date of November 21, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $13,054.92 firm-fixed-price delivery order is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen, through its Corporate Office division, is a significant supplier of pharmaceutical products and medical supplies to various U.S. government agencies,...
This federal contract award, valued at $157,141.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is a Delivery Order contract type with a Firm Fixed Price pricing structure. The contract's ultimate completion date is February 12, 2025. The contract covers the procurement of MENQUADFI VIAL 0.5ML medical supplies, which are likely...